IFITM3 promotes triple-negative breast cancer progression by regulating β-catenin localization
Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154335
DOI: 10.1016/j.bbrc.2026.154335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Heeyeon Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, beta Catenin, RNA-Binding Proteins, Membrane Proteins. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Korea Evaluation Institute of Industrial Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Interferon-induced transmembrane protein 3 (IFITM3) is best known as an antiviral protein, but accumulating evidence supports pro-tumorigenic functions across several cancers. Here, we examined IFITM3 in triple-negative breast cancer (TNBC). IFITM3 depletion suppressed MDA-MB-231 cell proliferation, migration, sphere formation, and xenograft tumor growth, whereas IFITM3 overexpression enhanced these phenotypes. IFITM3 depletion restored E-cadherin expression and increased membrane-associated E-cadherin-β-catenin complexes. These changes were accompanied by reduced nuclear active β-catenin and decreased Wnt/β-catenin transcriptional activity in cultured cells. Altered β-catenin localization was also observed in xenograft tumors. Conversely, IFITM3 overexpression enhanced WNT3a-responsive transcription and nuclear accumulation of active β-catenin. IFITM3 expression was elevated in breast tumors and was associated with shorter overall survival in a selected lymph-node-negative TNBC cohort. Together, these findings identify IFITM3 as a regulator of β-catenin localization and Wnt signaling that promotes epithelial-mesenchymal transition (EMT) and stem-like properties in TNBC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
- Department of Biological Sciences, Ajou University, Suwon, Republic of Korea. Electronic address: hurji@ajou.ac.kr.
- Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea. Electronic address: ehkim@unist.ac.kr.
Förderung
- Korea Evaluation Institute of Industrial Technology
- National Research Foundation of Korea
Zitieren
APA
Kim, H., Yu, Y., Park, Y., Kim, H., Yeo, M., Hur, J. Y., & Kim, E. (2026). IFITM3 promotes triple-negative breast cancer progression by regulating β-catenin localization. Biochemical and Biophysical Research Communications, 831, 154335. https://doi.org/10.1016/j.bbrc.2026.154335
Vancouver
Kim H, Yu Y, Park Y, Kim H, Yeo M, Hur JY, et al. IFITM3 promotes triple-negative breast cancer progression by regulating β-catenin localization. Biochemical and Biophysical Research Communications. 2026;831:154335. doi:10.1016/j.bbrc.2026.154335
BibTeX
@article{Kim2026,
author = {Kim, Heeyeon and Yu, Youngim and Park, Yuseon and Kim, Haein and Yeo, Mirae and Hur, Ji-Yeun and Kim, Eunhee},
title = {IFITM3 promotes triple-negative breast cancer progression by regulating β-catenin localization},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {831},
pages = {154335},
doi = {10.1016/j.bbrc.2026.154335}
}
EUVIMED